Characteristics of Errors in Open and Closed Trilateration Nets

Distance measurements have been more and more easy and accurate to carry out, and it is expected that distance mesurements may provide rather accurate results than angle measurements. Under these circumstances, caracteritics of errors in typical trilateration nets are investigated. The nets investigated are as follows: From single row of chains to pranimetrically extended nets in figure, open and closed networks with respect to external constraint, and with and without as to internal constraint. Computations are performed by use of the method of condition equations, and behaviours of error propagation and errors of coordinates of stations in the nets are shown in case of typical nets. For example, effects for decrease in error by composing a double row of chains and by enforcing external constraints are explained

LiNi₀.₅Mn₁.₅O₄ Cathode Materials Co-Doped with La³⁺ and S²⁻ for Use in Lithium-Ion Batteries

Spherical LiNi₀.₅Mn₁.₅O₄ particles co-doped with lanthanum (La) and sulfur (S) were synthesized by a facile co-precipitation assisted solid-state annealing method with stable oxysulfide La₂O₂S (x = 0, 0.3, 0.5, 0.7, 1.0, and 1.2 at%) as a dopant. The prepared composite materials exhibited a slight shrinkage of lattice parameters without any impurity phase under x <= 0.7 at%, and the Ni/Mn disordered arrangement in the spinel lattice increased with an increase in the ratio of dopants, as confirmed by X-ray diffraction and Raman spectroscopy. X-ray photoelectron spectroscopy and electrochemical measurements also clearly indicated that the residual Mn³⁺ in the cubic lattice could be effectively eliminated with the use of La₂O₂S dopants. The composite materials showed outstanding rate and cycling performance compared with those of the pristine material. Specifically, the material doped with 0.5 at% La₂O₂S showed a high reversible capacity of 115.9 mAh g⁻¹ at 10 C, and a remarkable cycling performance of 109.2 mAh g⁻¹ even after 200 cycles. All of these extraordinary performances were attributed to the synergistic effects of La and S in the spinel structure, which induce a suitable pathway for lithium ion and a robust architecture during the electrochemical assessment

Electrochemical Performance of Nanorod-like (La, Zr) Co-Doped Li-rich Li₁.₂Ni₀.₂Mn₀.₆O₂ OF ACCESS Cathodes for Use in Lithium-Ion Batteries

A lithium-rich layered structure in lithium-ion batteries (LIBs) has attracted much attention due to its high capacity of over 250 mAhg⁻¹ after activation. This could satisfy the requirements of next-generation energy-storage devices. However, a spinel-like impurity phase that forms from the pristine layered structure during cycling is considered to be harmful to the structure stability and Li⁺ mobility, resulting in undesired electrochemical performance. In this study, nanorod-like Li₁.₂Ni₀.₂Mn₀.₆O₂ with a three-dimensional architecture was synthesized by evaporative-crystallization with as-prepared nano-MnO₂ as a hard template. The structure stability and Li⁺ mobility of the nanorod-like Li₁.₂Ni₀.₂Mn₀.₆O₂ was improved by the addition of an appropriate molar ratios of (La, Zr) co-dopants. This combination exhibited outstanding capacity retention of 80.9% with a stable discharge capacity of 102 mAh g⁻¹ after 300 cycles under a high current density of 1000 mAg⁻¹ (corresponding to S C). This study suggests that the use of a multi-prong strategy that combines morphology control and co-doping should be an effective method for improving the high-rate performance of Li-rich materials

Magnetic properties and magnetic domain observation of ndfeb sintered magnets treated by grain boundary diffusion process with dyal co-sorption

Effective grain boundary diffusion (GBD) process with DyAl co-sorption is applied to enhance the coercivity of NdFeB sintered magnets. The coercivity of the magnet (HcJ = 1789 kA m⁻¹) subjected to the present GBD treatment was observed to be superior to that of the untreated magnet (HcJ = 1003 kA m⁻¹) and the conventional GBD magnet (HcJ = 1661 kA m⁻¹) treated with DyAl alloy. In the present GBD magnet, the DyAl co-sorption process facilitated Dy diffusion into the center region of the magnet (thickness: 3.5 mm), resulting in high coercivity. Further, magnetic domain observations were made using magnetic force microscopy (MFM) to observe the thermal demagnetization behavior of the present GBD magnet. The present GBD magnet suppressed the continuous domain reversal of adjacent grains; thus, the partially persistent single-domain structure remained, even at 453 K.M.Uenohara, H.Nishio, K.Toyoki, et al. Magnetic properties and magnetic domain observation of ndfeb sintered magnets treated by grain boundary diffusion process with dyal co-sorption. Materials Transactions 62, 1216 (2021); https://doi.org/10.2320/matertrans.MT-M2020389

In situ evaluation of podocin in normal and glomerular diseases

In situ evaluation of podocin in normal and glomerular diseases.BackgroundMutations of the NPHS2 gene are responsible for autosomal-recessive steroid-resistant nephrotic syndrome. Its product, podocin, faces the slit diaphragm area with its two ends in the cytoplasm of foot processes.MethodsWe generated rabbit polyclonal antibodies against conjugated peptides from human podocin N- and C-termini, and studied podocin and synaptopodin using kidney tissues of normal humans and those with glomerular diseases.ResultsAntipodocin antibodies detected the original 42 kD fragment and an extra smaller fragment by Western blot analysis using human isolated mature glomeruli. RNA analysis showed two bands, the original and the other of a decreased length. Immunohistochemically, podocin was detected in a linear pattern along the glomerular capillary loop. Antipodocin antibody (C-terminal) stained the smooth muscles of renal arterioles and aorta. Among 42 patients, podocin was normally expressed in glomeruli in purpura nephritis, IgA nephropathy (IgAN), and minimal-change disease (MCD), while it was either decreased or absent in most subjects with focal segmental glomerulosclerosis (FSGS). The expression of synaptopodin was similar to that of podocin, although some discrepancy existed.ConclusionAlthough indirect, our data suggest the existence of a vascular isoform of podocin with a different molecular mass. We propose that examination of podocin expression may help differentiate MCD from FSGS

Combination chemotherapy for small cell carcinoma of the lung: evaluation of four-drug combination of cyclophosphamide, vincristine, methotrexate, and procarbazine.

Forty-one patients with small cell carcinoma of the lung were treated with a four-drug combination of cyclophosphamide, vincristine, methotrexate, and procarbazine. The response rate was 68% (28 responded among 41 patients), with 10 complete responses (24%) and 18 partial responses (44%). The median survival time from the initiation of chemotherapy was 11 months for patients with limited disease and 8 months for those with extensive disease. Patients who achieved complete response survived significantly longer than those who did not; the median survival time for complete responders was 14.5 months, compared to 8.5 months for partial responders and 6 months for non-responders. Myelosuppressive toxicity remained within acceptable limits, with 5% incidence of leukocytopenia (less than 1,000/microliter) and 7% incidence of thrombocytopenia (less than 50,000/microliter) following the first course of the regimen.</p

Geochemical characteristics of back-arc basin lower crust and upper mantle at final spreading stage of Shikoku Basin: an example of Mado Megamullion

AbstractThis paper explores the evolutional process of back-arc basin (BAB) magma system at final spreading stage of extinct BAB, Shikoku Basin (Philippine Sea) and assesses its tectonic evolution using a newly discovered oceanic core complex, the Mado Megamullion. Bulk and in-situ chemical compositions together with in-situ Pb isotope composition of dolerite, oxide gabbro, gabbro, olivine gabbro, dunite, and peridotite are presented. Compositional ranges and trends of the igneous and peridotitic rocks from the Mado Megamullion are similar to those from the slow- to ultraslow-spreading mid-ocean ridges (MOR). Since the timing of the Mado Megamullion exhumation corresponds to the very end of the Shikoku Basin opening, the magma supply was subdued and highly episodic, leading to extreme magma differentiation to form ferrobasaltic, hydrous magmas. In-situ Pb isotope composition of magmatic brown amphibole in the oxide gabbro is identical to that of depleted source mantle for mid-ocean ridge basalt (MORB). In the context of hydrous BAB magma genesis, the magmatic water was derived solely from the MORB source mantle. The distance from the back-arc spreading center to the arc front increased away through maturing of the Shikoku Basin to cause MORB-like magmatism. After the exhumation of Mado Megamullion along detachment faults, dolerite dikes intruded as a post-spreading magmatism. The final magmatism along with post-spreading Kinan Seamount Chain volcanism were introduced around the extinct back-arc spreading center after the opening of Shikoku Basin by residual mantle upwelling

Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.

Twenty-seven previously untreated patients with unresectable non-small cell lung cancer were treated with a 3-drug combination of ifosfamide, cisplatin, and vindesine as a phase II study. Patients received ifosfamide, 1.3g/m2, on days 1 to 5; cisplatin, 20mg/m2, on days 1 to 5; and vindesine, 3mg/m2, on days 1 and 8; with a sufficient parenteral hydration. Courses were repeated every 4 weeks. Twenty males and seven females with a median age of 61 years were treated and fully evaluated. Five patients had stage IIIA, seven had stage IIIB, and 15 had stage IV disease. One patient with adenocarcinoma achieved a complete response and 16 achieved a partial response, for an overall response rate of 63% (95% confidence limit: 45% to 81%). The median duration of response was 34 weeks (range: 9 to 52 weeks). The median survival time was 58 weeks for patients with IIIA/B disease, and 33 weeks for those with IV disease. The major toxicity was myelosuppression, however, it was generally well-tolerated. These results indicate that the 3-drug combination is active against non-small cell lung cancer and warrants further clinical trials.</p